BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Timing is Right for Big Pharma to Add Nuvilex Technology to Its Pipeline

  March 21, 2013

   · 

  2 min read
• Policy

  FDA Advisory Committee Votes Favorably on Abbott Laboratories’s Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who are Too High Risk for Surgery

  March 21, 2013

   · 

  4 min read
• Genetown

  Firefly BioWorks Releases Expanded Multiplexed microRNA Assay

  March 21, 2013

   · 

  1 min read
• Business

  Bioject Medical Technologies Inc. Enters Into Three Distribution Agreements

  March 21, 2013

   · 

  1 min read
• Biotech Bay

  InterMune, Inc. Release: Esbriet® (pirfenidone) Receives Positive Final Appraisal Determination From National Institute for Clinical Excellence (NICE) for Idiopathic Pulmonary Fibrosis (IPF)

  March 21, 2013

   · 

  7 min read
• Biotech Bay

  Charisela® Technologies, Inc. Announces New HyFlo-Ig® Product Line; Begins Shipping Its No Dilution, No Wash, 45 Minute Mouse and Human IgG Flow Cytometry Assays

  March 21, 2013

   · 

  1 min read
• BioCapital

  BioElectronics Corporation Announces RecoveryRx™ Product Distribution in Ireland

  March 21, 2013

   · 

  1 min read
• Biotech Beach

  Sequenom Inc. Announces the Availability of Heredi-T™ Cystic Fibrosis Carrier Screening LDT Through Sequenom CMM

  March 21, 2013

   · 

  6 min read
• Business

  Fibrocell Science, Inc./University of California, Los Angeles (UCLA) Study on Human Skin Cells Yields Promising Results

  March 21, 2013

   · 

  1 min read
• Drug Development

  Intarcia Therapeutics, Inc. Enrolls First Patients in “Freedom” Global Phase 3 Program for ITCA 650 in Type 2 Diabetes

  March 21, 2013

   · 

  7 min read